Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

CLR-Seq: A pipeline to identify bacterial microbiota species with immune-relevant glycan moieties through human C-type lectin receptor interaction

  • Jasper Mol,

    Roles Conceptualization, Formal analysis, Investigation, Validation, Methodology, Project administration, Visualization, Writing – original draft, Writing – review & editing

    Affiliation Department of Medical Microbiology and Infection Prevention, Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands

  • Rob van Dalen,

    Roles Conceptualization, Funding acquisition, Methodology, Project administration, Supervision, Writing – original draft, Writing – review & editing

    Affiliation Department of Medical Microbiology and Infection Prevention, Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands

  • Yvonne Pannekoek,

    Roles Supervision, Writing – original draft, Writing – review & editing

    Affiliation Department of Medical Microbiology and Infection Prevention, Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands

  • Malgorzata E. Mnich,

    Roles Resources

    Current Affiliation: Innate Immunity Unit, Institut Pasteur, Université Paris Cité, Inserm U1223, Paris, France

    Affiliation Department of Medical Microbiology, UMC Utrecht, Utrecht, The Netherlands

  • Marcel R. de Zoete,

    Roles Resources, Methodology

    Affiliation Department of Medical Microbiology, UMC Utrecht, Utrecht, The Netherlands

  • Mark Davids,

    Roles Data curation, Formal analysis

    Affiliation Department of Experimental Vascular Medicine, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands

  • Hilde Herrema,

    Roles Resources

    Affiliation Department of Experimental Vascular Medicine, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands

  • Nina M. van Sorge

    Roles Conceptualization, Funding acquisition, Methodology, Project administration, Supervision, Writing – original draft, Writing – review & editing

    n.m.vansorge@amsterdamumc.nl

    Affiliations Department of Medical Microbiology and Infection Prevention, Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam UMC, location University of Amsterdam, Amsterdam, The Netherlands, Netherlands Reference Laboratory for Bacterial Meningitis, Amsterdam UMC, location AMC, Amsterdam, The Netherlands

Abstract

Bacterial glycans are key components in immune interactions. We lack insight into the diverse glycan landscape present in complex microbial communities since current -omics techniques do not capture this post-translational information. Here we employed C-type lectin receptors (CLRs), which are dedicated innate glycan-sensing receptors, as probes for bacterial cell sorting in combination with 16S rRNA gene sequencing to identify microbiota species with a specific CLR-reactive glycan profile. We established our experimental CLR-sequencing (CLR-seq) pipeline using soluble fluorescently-labeled human macrophage galactose C-type lectin (MGL, CD301) and langerin (CD207). Both receptors identified known langerin- or MGL-interacting Staphylococcus aureus strains in a synthetic microbial community even when present at low abundance. Subsequent application of CLR-seq on fecal microbiota samples from healthy donors identified specific langerin- and MGL-interacting bacterial species that were subsequently validated as monocultures. In summary, CLR-seq is a modular platform that allows identification of human microbiota species based on CLR-interacting glycans with easy expansion to other CLRs or microbiota samples from patients. Given that CLRs are densely expressed on dendrites of antigen-presenting cells, this pathway may play a role in cross-barrier recognition and sampling of the environment during homeostasis.

Introduction

The human body hosts a large variety of bacteria, collectively known as the microbiota. The composition of the microbiome is associated with health benefits, but also pathologies through changes in metabolites, digestive capacity or altered inflammatory properties [13]. To maintain homeostasis, there is a reciprocal interaction between the microbiota and the local immune system. In addition, microbiota-triggered antibody responses even extend into the systemic compartment, offering protection against pathogens [4,5]. Application of -omics technologies has allowed the identification of species and associated transcriptomes, proteins and metabolites within microbiota samples, allowing association of certain -omics signatures with specific pathologies. Further studies have subsequently been able to functionally underpin specific microbes or metabolites to health and disease processes. In contrast to this wealth of information, we currently have limited insight into the microbiota glycome, i.e., the glycan composition of the human microbiome and how this impacts human health and disease.

Glycans represent an integral part of the bacterial cell wall, providing bacterial integrity and viability [6]. Bacterial glycans are often distinct from their human counterparts and the specific glycan composition can contribute to tolerogenic or homeostatic signals through interaction with pattern recognition receptors (PRRs) on innate immune cells [7,8]. In the context of infection, it is well established that the expression of capsular polysaccharides contributes to bacterial virulence and immune escape [9]. Consequently, directing specific antibody responses towards bacterial glycans, e.g., through use of polysaccharide capsule in glycoconjugate vaccines, has proven highly successful in disease protection, saving millions of lives globally [10]. Also, in the context of health-associated microbiota, glycosylation of commensal bacteria contribute to the interaction with the host, influencing a variety of homeostatic processes, including epithelial barrier integrity and immune modulation [11]. In contrast to proteins, glycans are not directly encoded on the bacterial genome, but are synthesized by complex biosynthetic pathways involving multiple building blocks and enzymes. This hampers the application of routinely-used -omics approaches to capture the microbiota glyco-landscape. Similarly, glycan-microarrays are a useful technique for studying glycan-protein interactions, yet they are unable to capture the diversity of the microbiota glycome at a species-specific level [12,13]. Consequently, the microbiota glycome and its impact on human health and disease represents a major knowledge gap.

Coupling fluorescence-based cell sorting with genomic sequencing has proven a powerful pipeline for identifying subsets of microbiota species with specific immunological properties. For example, IgA-seq allowed identification and subsequent characterization of colitogenic bacteria in patients suffering from inflammatory bowel disease based on differential IgA coating [14,15]. Similarly, two recent studies used glycan-binding lectins as probes to identify microbiota species or even strains with specific glycan patterns. The Glycan-seq technology used 39 different DNA-barcoded non-mammalian lectins to compare glycan profiles of adult mice and pup microbiota samples [16]. The Lectin-seq technology showed the selective and distinct labeling of commensals by two soluble human innate lectins, mannose-binding lectin and intelectin-1, to human fecal microbiota species [17]. In addition to soluble lectins, the repertoire of innate immune receptors also encompasses a wide range of cell-expressed C-type lectin receptors (CLRs), which are abundantly expressed by antigen-presenting cells (APCs) that line the mucosal surfaces and sample the environment through trans-barrier sampling [1820].

In this study, we aimed to examine the interactions between the bacterial gut microbiota and APC-expressed CLRs. To this end, we have developed a pipeline, called CLR-sequencing (CLR-seq), which combines fluorescence-based sorting of CLR-reactive bacteria with 16S rRNA gene sequencing. As a proof-of-concept, we used two human CLRs with distinct glycan specificities, i.e., the macrophage galactose-like C-type lectin (MGL; CD301), which predominantly interacts with terminal N-acetylgalactosamine (GalNAc) residues, and langerin (CD207), which binds high mannose structures, fucose, β-glucan and N-acetylglucosamine (GlcNAc) [21,22]. Both CLRs recognize distinct glycan moieties on the cell wall of specific bacterial pathogens, such as Staphylococcus aureus. Moreover, the CLR-bacteria interaction modulates the maturation and cytokine expression of the interacting APC [23,24]. Using langerin and MGL, we show the ability of these CLRs to identify S. aureus in bacterial mixtures based on their expressed glycan profile. Next, we applied the two CLRs to fecal microbiota samples from three healthy human donors to identify microbiota species that express MGL and/or langerin-reactive glycans. We envision this approach to open new avenues to study the interaction between host immune system and microbiota glycome and uncover interaction that are relevant to human health and disease.

Results

Soluble CLRs identify bacteria with specific glycan motifs in synthetic mixtures

The aim of this study was to establish a pipeline for identification of bacterial microbiota species that can be recognized by human APC-expressed CLRs. For this proof-of-concept study, we used the macrophage CLR MGL (CD301) and the Langerhans cell CLR langerin (CD207), which have distinct glycan binding specificities [21,22]. First, we validated that our approach could selectively identify and extract bacteria based on their surface glycan composition from a mixed bacterial community. To this end, we created a synthetic microbial community of equal proportions of four bacterial species, i.e., two Gram-positive (Streptococcus thermophilus and Listeria monocytogenes) and two Gram-negative bacteria (Escherichia coli and Alcaligenes faecalis) that did not bind to either recombinant human langerin or MGL (Fig 1A). We then added CLR-binding S. aureus bacteria to this mixture in a proportion of 20% relative to the total community. For MGL, we used S. aureus PS187, for which we previously showed that MGL binds GalNAc attached to surface-anchored wall teichoic acid (WTA) [23]. S. aureus strain N315 was used to validate langerin-based identification and sorting in line with our observations that langerin binds this strain through the β-linked GlcNAc on WTA [24].

thumbnail
Fig 1. CLRs can identify bacteria with specific glycan patterns in a synthetic microbial community.

A recombinant human MGL or langerin-FITC staining of the five bacterial species that were used to create a synthetic microbial mixture. S. aureus PS187 and N315 are included as CLR-binding positive controls. B Schematic overview of the procedure. Cell trace yellow (CTY)-stained S. aureus N315 or PS187 (identified in PE channel) were spiked into the synthetic microbial community and the mixed population was subsequently stained with either recombinant human MGL or langerin-FITC. The CLR-positive-and negative populations were sorted. C Proportion of CTY-stained S. aureus in the total, CLR-positive and CLR-negative sorted populations. The exact percentages of CTY+ bacteria are shown for each bar. Data shown is representative of two independent experiments.

https://doi.org/10.1371/journal.pone.0356059.g001

Both S. aureus strains were labeled with Cell Trace Yellow (CTY) before mixing the strains, allowing identification of these bacteria in the phycoerythrin (PE) channel and discriminate it from the synthetic bacterial mixture (S1 Fig). Subsequently, the bacterial mixture was stained with FITC-labeled his-MGL or langerin and FITC-positive and -negative bacteria were sorted using fluorescence-based cell sorting (Fig 1B). Re-analysis of sorted CLR-positive and -negative populations showed strong enrichment of CTY-stained S. aureus in the CLR-positive population and depletion in the CLR-negative populations (Fig 1C). These results show that fluorescence-based cell sorting of bacteria based on CLR-staining is glycan specific.

Bacterial species are present at different abundances in gut microbiota. Therefore, we aimed to show that CLR-based cell sorting would allow identification of low-abundant bacteria in a complex synthetic microbial community by decreasing the proportion of CTY-stained S. aureus PS187 or N315 cells to 10% and 1% of the total synthetic bacterial community. Similar to previous results, bacteria could be discriminated from the synthetic bacterial community by double staining even at lower abundance (S1 Fig). Sorting and re-analysis of CLR-positive and -negative bacteria showed that independent of the proportion of S. aureus added to the mixture, CTY-positive S. aureus were strongly reduced in the negative population (Fig 1C). Complementary, even at 1% abundance, the positively-sorted fractions were strongly enriched for S. aureus, with approximately 80% CTY-positive cells at 1% presence (Fig 1C). Taken together, these data indicate that bacterial strains with specific glycan motifs can be identified and sorted from more complex microbial communities.

CLR-sequencing on human microbiota

We have thus far stained and identified known CLR-binding S. aureus strains in a synthetic community of limited diversity. To allow identification of new bacterial species that are recognized by human MGL or langerin, we coupled CLR-based binding and sorting to 16S rRNA gene sequencing. We first stained isolated human fecal microbiota with the DNA stain SYTO60 to determine the bacterial presence and purity of our isolation protocol. On average, 85% of events was SYTO60 positive (S2A Fig), implying that our isolation protocol removes most debris and non-bacterial particles. Having validated our bacterial purity, we next assessed the interaction between FITC-labeled MGL or langerin upon incubation of the isolated fecal material. The isolated fecal bacteria were stained with FITC-labeled MGL or langerin and the CLR-positive populations were obtained through fluorescent cell sorting. Re-analysis of the CLR-positive sorted fractions showed 89% and 94% SYTO+ events for langerin and MGL, respectively, indicating the high presence of bacterial particles in these samples (S2A Fig). Next, we tested the effect of the calcium chelator EGTA on CLR binding to fecal microbiota, as CLR interactions are calcium dependent [25]. We observed donor specific differences in EGTA-mediated blocking of MGL and langerin binding of microbiota (S2B and C Figs). EGTA blocking appeared more effective on MGL than on langerin binding and the blocking was more effective for donors with higher CLR bound populations. This indicates the potential of non-specific binding to a subset of bound bacteria after fluorescence-based sorting. Therefore, post-sorting validation is crucial for discriminating biological binding from non-specific binding.

Having established that our pipeline allows identification of CLR-reactive bacterial strains/species with little non-bacterial impurities, we applied the CLR-seq pipeline to isolated fecal microbiota samples from three individual healthy human donors. Fecal microbiota samples were incubated with MGL or langerin and positive fractions were sorted using fluorescence-activated cell sorting. Additionally, we identified and sorted IgA-positive bacteria from the same fecal samples, as it was previously shown that this pipeline allows identification of bacterial species with immunostimulatory properties [14,15]. We observed differences in the proportion of IgA-, MGL- and langerin-reactive bacteria of the healthy donors, where the proportion of CLR-reactive bacteria was smaller compared to the IgA-positive fraction (Fig 2A).

thumbnail
Fig 2. Characteristics of CLR- and IgA-positive populations from fecal microbiota.

A MGL-, langerin-, and IgA-positive bacterial populations were collected from fecal microbiota samples (n = 3 healthy donors), using fluorescence-based cell sorting, and analyzed with 16S rRNA gene sequencing. B Multilevel principle component analysis of all sequenced samples with donor-specific effects removed prior to ordination. C Relative abundances at the genus level for genera that were among the 10 most abundant genera in at least one sequenced sample.

https://doi.org/10.1371/journal.pone.0356059.g002

Subsequently, DNA was extracted from the total unsorted microbiota input as well as IgA- and CLR-positive sorted fractions and analyzed by 16S rRNA (V3-V4 regions) gene sequencing on isolated DNA from these fractions to identify the bacteria species in the enriched fractions. The reads were mapped against zero-radius operational taxonomic unit (zOTU) sequences, after which taxonomy was assigned to obtain the bacterial abundances. No contaminating signatures in the post-sorting reagents were identified. We observed a decrease in species diversity based on the Shannon Diversity index post-sorting when compared to the unsorted, total populations (S3A Fig). Importantly, the sequencing data varied most strongly between the total unsorted microbiota samples and the sorted IgA and CLRs fractions based on a multilevel principal component analysis (PCA) with removal of donor-specific effects prior to ordination (Fig 2B). Based on the 16S rRNA gene sequencing, relative abundances were determined at various taxonomic levels for the total populations and sorted samples. Despite interindividual variation between donors at the genus taxonomic level, some shared changes in relative abundances could be observed (Fig 2C and S1 Table). For all three donors, the relative abundance of Bacteroides bacteria was decreased for MGL-, langerin-, and IgA sorted samples. In contrast, the proportion of Butyricicoccus and Coprococcus 1 was increased in all three MGL sorted donor samples. The langerin samples for donor 1 and 2 showed an increase in relative abundance for Blautia and Faecalibacterium bacteria, respectively. When examining the sample composition at the taxonomic species level, we observed a large presence of specifically Blautia obeum in donor 1 and a Faecalibacterium sp. (zOTU_579) in donor 2 of the langerin sorted samples (S3B Fig and S2 Table).

Using the relative abundances from the 16S rRNA gene sequencing analysis and fraction sizes of the sorted populations, positive probability scores were calculated for all zOTUs as described previously [26]. This method is less influenced by the pre-sort taxonomic composition of the microbiota than conventional approaches. To avoid the introduction of potential contaminants during sample preparation, collection or sequencing, we only included zOTUs that were detected in the total population of all three donors and had a relative abundance of >0.1% in at least two donors. Probability scores of zOTUs in the MGL-, langerin-, or IgA-positive samples did not correlate with their relative abundance in the total population for any of the donors, suggesting that species abundance in the unsorted microbiota population does not influence CLR- or IgA-binding (S4 Fig).

Plotting the individual values for the zOTUs with the highest and lowest average probability scores showed the individual differences in binding of specific species (Fig 3). In the zOTUs with the highest average MGL binding (Fig 3A), donor 2 often showed the highest score, whereas for langerin (Fig 3B) and IgA (S5 Fig) this varied more among the donors. For both MGL and langerin, the zOTUs with the lowest average positive probability scores consisted mostly of Bacteroides sp. with a number of these being completely depleted in the sorted sample, as indicated by a positive probability score of 0.

thumbnail
Fig 3. CLRs bind to specific human gut bacteria species.

Probability scores were calculated for CLR binding based on the 16S rRNA gene sequencing relative abundances. Shown are the 10 zOTUs with either the highest (grey background) or lowest average probability scores (white background) for individual donors for A MGL or B langerin. Open circles are used for donors where the zOTU had < 0.1% relative abundance in the total population.

https://doi.org/10.1371/journal.pone.0356059.g003

Marvinbryantia sp. zOTU_690 and Ruminococcaceae UCG-005 sp. zOTU_141 were among the zOTUs with the highest average probability scores for MGL and langerin. Interestingly, these species also showed high IgA binding (S5 Fig). Complementary, zOTUs with low probability scores for CLR binding also had low IgA probability scores (S5 Fig). Including all zOTUs in the sorted fractions, the average probability scores of the CLR- and IgA-positive zOTUs correlated significantly (S6 Fig).

Validation of CLR binding to species identified by CLR-seq

Interestingly, we observed Blautia sp. zOTUs in both the highest and lowest average langerin probability scores. This indicates that CLR-seq may discriminate within the taxonomic genus level between species expressing different glycan profiles [27]. We therefore deemed it important to validate a number of species in the CLR-binding fraction as monoculture.

Bifidobacterium bifidum, a gut commensal with probiotic characteristics and present in the intestinal tracts of nearly every individual [28], and Dorea formicegenerans, another intestinal commensal bacterium, were among the species with the highest average probability scores for MGL (Fig 3A). To validate the CLR-seq results of these donors, MGL binding was tested on monocultures of a B. bifidum and D. formicegenerans strain. MGL interacted with B. bifidum and this binding was dependent on the carbohydrate recognition domain (CRD) of MGL and bivalent cations, since MGL binding was abrogated by the addition of GalNAc and significantly reduced in the presence of EGTA, respectively (Fig 4A and S7A Fig). No binding of MGL to the D. formicenegerans monoculture was observed (Fig 4A and S7A).

thumbnail
Fig 4. Validation of CLR binding to bacterial species identified through CLR-seq.

Binding of A recombinant human MGL and B recombinant human langerin-FITC to bacterial species monocultures identified by CLR-seq. CLRs were used at a concentration of 25 µg/mL, similar to the concentration used during sorting. Binding was blocked using GalNAc or mannan for MGL and langerin, respectively, and with the calcium chelator EGTA. Statistical comparisons indicated are the blocked or unstained/α-his FITC antibody-stained bacteria compared to the CLR stained control. Data are shown as the mean of the geometric mean fluorescence intensity (FI) ± standard error of mean from three independent experiments. *, p < 0.05; ***, p < 0.001; ****,p < .0001.

https://doi.org/10.1371/journal.pone.0356059.g004

For langerin binding, the gut commensal bacterium Anaerostipes hadrus was among zOTUs with the highest average probability scores (Fig 3B). Therefore, we tested binding of this CLRs to an A. hadrus monoculture (Fig 4B and S7B Fig). We observed langerin-FITC binding, although this binding was not abrogated by the addition of EGTA, and even increased by the addition of mannan, suggesting that this binding was non-specific.

To avoid the interference of contaminants in our 16S rRNA gene sequencing analysis, we had removed zOTUs that were not detected in the total population of their respective donor. However, when examining the removed zOTUs more closely, we observed consistent presence of various zOTUs in the CLR-positive fractions of our three donors. For both MGL and langerin-positive fractions, we detected the genus Aquamicrobium, which was first described in activated sewage sludge [29]. In our 16S rRNA gene sequencing data, this genus consisted of a single zOTU attributed to two species, A. lusatiense and A. defluvii. Additionally, we identified two zOTUs at the species level within the genus Corynebacterium with consistent presence in the langerin-positive fraction. These were C. accolens, an abundant nasal commensal, and C. appendicis, which was first isolated from the abdominal swab of an appendicitis patient [30,31]. To verify CLR binding to the mentioned species, an individual strain of each species was grown as a monoculture and incubated with recombinant human MGL or langerin, corresponding to the sorted fractions in which they were identified (S7 Fig). MGL bound significantly to A. defluvii and binding was abrogated by the addition of GalNAc and EGTA (Fig 4A and S7A Fig), suggesting that the recognition by MGL occurred through the CRD and was calcium dependent. In contrast, only minor MGL binding to A. lusatiense was observed, which was not blockable by either GalNAc or EGTA and therefore concluded to be non-specific (Fig 4A, S7A Fig). For langerin, we observed significant binding to A. defluvii and a loss of binding by the addition of mannan or EGTA (Fig 4B and S7B Fig). No langerin binding to A. lusatiense was observed (S7B Fig). C. appendicis and C. accolens both bound to recombinant human langerin in a CRD- and calcium-dependent manner (Fig 4B and S7B Fig), although the binding appeared to be saturated at a lower concentration for C. appendicis. The combined results of CLR binding to the individual species identified by 16S rRNA gene sequencing highlights the potential of CLR-seq to specifically identify bacteria that can be recognized by CLRs.

Discussion

Bacterial glycans are critical for both cell viability, as well as interaction with the host-immune system. However, the complex nature of the biochemical pathways involved in glycan synthesis complicates glycan research on the level of diverse microbial communities, such as the gut microbiota. Previously, microbiota glyco-profiling was performed using a large panel of non-mammalian lectins and two soluble human lectins [16,17]. Here we analyzed the human microbiota through C-type lectin receptor-sequencing (CLR-seq), which combines interaction with human surface-expressed CLRs with 16S rRNA gene sequencing. We present proof-of-principle that CLR-seq can be used as a platform to comprehensively determine the microbiota-binding capabilities of human CLRs. The approach can easily be adapted to other host CLRs or microbiota samples of interest, for example from different mucosal sites or from patients with a specific clinical condition.

To establish proof-of concept for CLR-seq, we used MGL, which is expressed by tissue resident macrophages and langerin, a Langerhans cell-specific CLR, since we have extensive experience with these two CLRs in host-microbe interaction [23,24]. We chose to apply CLR-seq on fecal microbiota samples since this is the most abundant microbial community present in the human body, thereby yielding the most diverse glycome. Currently, we have limited insight into the exact APC subsets and associated CLRs that line the different intestinal barriers in humans. In mice, the presence of the murine MGL homologue was found in colon tissue [32]. Additionally, MGL expression was found on APCs located in the lamina propria of the jejunum [33]. Although langerin is most likely not present in the gut, the CLR DC-SIGN, predominantly expressed by dendritic cells, was identified in human Peyer’s patches [34] and shows substantial overlap in ligand binding with langerin [18]. The incorporation of additional CLRs, such as DC-SIGN, would give a more complete overview of the glycan binding capabilities of the mucosal immune system of the gut.

We showed that CLR-seq can specifically target bacteria based on their glycan moieties, even at low abundance in a synthetic microbial community. We then applied CLR-seq to the fecal microbiota of three healthy human donors. To identify bacteria in the unsorted and CLR-sorted fractions, we used 16S rRNA gene sequencing. This posed limitations for the downstream workflow. While we obtained general taxonomic information with a limited bacterial input (200,000 positive events sorted), identification at the species level was not possible for most zOTUs, which was also observed to a lesser extent at the genus level. The current method could also benefit from an increase in sorted events to include a greater variety of bacterial species and increased taxonomic resolution, e.g., through application of next generation whole metagenome sequencing, since this would provide a more detailed insight into the bacterial identity and characteristics that confer interaction with innate CLRs.

Since bacterial surface composition of glycans can be strain-specific or even phase variable [6], this could result in the unsuccessful validation of certain species. Indeed, we observed that within a genus, individual zOTUs could have either high or low CLR-probability scores. Furthermore, as CLR-seq studies the host-microbe interaction in a complex bacterial community, this could further contribute to disparities between the identified species in the sorted sequencing data and the monocultures in the laboratory setting. Indeed, these factors highlight the necessity for laboratory validation of identified species. Strain-level information may also resolve discrepancies for species that are inconsistently identified in microbiota screens or are being associated with certain host pathologies. Furthermore, expanding the number of donors could provide more information about conserved recognition of bacterial species by CLRs. Lastly, culturing bacteria directly after sorting could result in a variety of CLR-binding candidates, depending on the culturability of the sorted species.

For the zOTUs we identified in our CLR-binding fractions, we could validate MGL binding to Bifidobacterium bifidum, a human commensal, in a CRD-dependent manner. MGL predominantly binds to galactose and GalNAc residues, which are present in certain B. bifidum polysaccharide structures [35]. The non-specific langerin binding to A. hadrus and lack of MGL binding to D. formicegenerans may be related to the factors described above, i.e., strain variation and environmental conditions that affect glycan patterns and expression. Furthermore, the lack of MGL binding to D. formicegenerans could be the result of non-specific binding, such as binding of the bacteria to the fluorescent labeling of the CLR, further highlighting the need for post-sorting/sequencing validation.

We observed a significant correlation between CLR- and IgA binding for the microbiota species identified by 16s rRNA gene sequencing. Interestingly, it has been described that affinity-matured, microbiota-binding IgA is often glycan-reactive [36,37]. We therefore speculate that CLRs and IgA may target similar glycan structures. Alternatively, as IgA is glycosylated, there is the possibility that the used CLRs bind to these IgA-attached glycan moieties [38], resulting in non-specific binding of CLRs to IgA-coated bacteria. Applying CLR-seq to fecal bacteria of patients with IgA deficiencies would provide a setting without this potential CLR-IgA binding and would therefore be an interesting angle for future research into the microbiota glycome. However, the CRD-dependent binding of B. bifidum as a monoculture shows that this is certainly not the case for all CLR bound bacteria. Additionally, we could validate binding to species that were suspected environmental contaminants. These species were not detected in the unsorted microbiota populations, but were consistently present in the CLR positive populations. It highlights that, while it is good practice to remove species not present in the total fecal population for post-sequencing analysis, there is merit in examining species only detected in sorted samples. This suggests the selectivity of CLR-seq even at very low abundances and independent of IgA coating.

In the context of infection, CLRs expressed on APCs have an important role of sensing a wide array of pathogens, including viruses, bacteria and fungi, through interaction with specific microbial glycan patterns that are abundantly expressed at the surface [18,39,40]. But also during homeostasis, APCs constantly probe the local microbiota and bacterial antigens at host-barrier sites by extending their dendrites into the lumen [5,19,20]. This sampling and further processing contributes to the development of local and systemic immunity that help maintain homeostasis but also clearance of invading pathogens [41,42]. Interestingly, CLRs are densely expressed on the probing dendrite tips [43,44]. Hence, CLRs on APC dendrites are uniquely equipped and localized to selectively sample bacteria from a complex microbiota community based on their glycan specificity during homeostasis. As an outlook, we therefore anticipate that CLR-seq may provide a greater understanding of microbiota species selection by glycan-dependent innate immune sampling by mucosal APCs.

Overall, our results demonstrate that CLR-seq can identify bacterial microbiota species based on their glycan pattern or IgA binding from complex microbial communities. This technique can easily be expanded to an increased panel of recombinant immune receptors, the incorporation of samples from different mucosal compartments, as well as the comparison of the microbial glycan content of healthy individuals with patients with underlying disease, making it a new tool for functional microbiota research.

Methods

Fecal donor samples

The fecal donor samples used were obtained retrospectively from the Amsterdam University Medical Center (Amsterdam, the Netherlands) and accessed for research purposes between 01-05-2022 and 31-07-2025, where they were previously collected as part of the PIMMS study (NL67136.018.18) [45]. This study was approved by the Medical Ethical Reviews Committee at Amsterdam UMC (previously Amsterdam Medical Center (AMC)). Information that could identify the individual participants was not accessible during data collection.

Bacterial strains and culture conditions

The bacterial strains used in this study are listed in Supporting information S1 File. Staphylococcus aureus and Aquamicrobium strains were grown in Tryptic Soy broth (TSB; Oxoid) and Escherichia coli in Luria Bertani (LB; Oxoid) broth. Streptococcus thermophilus was grown in Todd-Hewitt broth supplemented with 1% yeast extract (THY; Oxoid) in the presence of 5% CO2 and Listeria monocytogenes in Brain Heart Infusion (BHI; Oxoid) broth. Overnight cultures were diluted to an optical density 600 nm (OD600) of 0.05 in fresh medium and grown to mid-exponential phase, after which bacteria were harvested by centrifugation. Alcaligenes faecalis and the Corynebacterium species were grown on Columbia blood agar (Oxoid), with Corynebacterium appendicis grown in a microaerophilic environment. Bacteria were collected from plate using an inoculation loop, and washed with Tris-sodium-magnesium buffer (TSM: 20 mM Tris; Roche, 150 mM NaCl; Merck, 2 mM CaCl2; Merck, 2 mM MgCl2; Merck, pH 7.0) + 0.1% Bovine Serum Albumin (BSA). Bifidobacterium bifidum and Dorea formicegenerans were isolated from human feces as described previously [14]. Subsequently, they were grown in an anaerobic chamber in Gut Microbiota medium (GMM) [46]. Overnight cultures were diluted in fresh medium to an OD600 of 0.05 and grown for 6 hours, after which they were harvested by centrifugation. Anaerostipes hadrus was cultured in modified yeast extract, casitone and fatty acid (YCFA) medium [47] supplemented with 30 mM glucose. Overnight cultures were diluted in fresh medium (1:10) and grown for 4 hours, after which they were harvested by centrifugation. All species were grown at 37°C, except for the Aquamicrobium species, which were grown at 30°C.

Expression and purification of recombinant human MGL

The extracellular domain of human MGL (CLEC10A) was expressed and purified as described previously [48]. A gBlock encoding the open reading frame of human MGL and a C-terminal LPETGG-6xHis tag were cloned into a pcDNA34 expression vector (Invitrogen). Expression of recombinant hMGL-his proteins was performed in Expi293F cells (Life Technologies), which were cultured in Expi293 Expression Medium (Life Technologies). The protein was purified from the supernatant using affinity chromatography (ÄKTA Pure, GE Healthcare Life Sciences) using a Nickel column (GE Healthcare Life Sciences) as previously described [49]. Eluate was dialyzed against 300 mM NaCl 50 mM Tris pH 7.8 at 4°C.

Staining and flow cytometric analysis of bacterial strains

Bacteria were collected from broth culture by centrifugation or from plate with an inoculum loop after overnight growth, washed with and resuspended in TSM + 0.1% BSA after centrifugation (3,600 x g, 10 min, 4°C). Bacterial abundance was determined by optical density at 600 nm or using flow cytometry with Precision Count Beads (Biolegend 424902) using a BD FACSymphony or BD FACSCanto.

For langerin and MGL specificity analysis in synthetic microbial communities, S. aureus strains N315 and PS187 (Supplementary information S1 File) were used as positive controls, respectively [23,50]. Both S. aureus strains were fluorescently-labeled with Cell Trace Yellow (CTY; Invitrogen) as per manufacturer’s instructions and mixed at desired relative abundances in the synthetic microbial community consisting of 107 bacterial cells (quantified by flow cytometry). Subsequently, the bacterial mixture was stained with either FITC-labeled recombinant langerin (kindly provided by Prof. Christoph Rademacher, University of Vienna, Austria) [22] or his-tagged recombinant human soluble MGL at 25 µg/mL in TSM + 0.1% BSA for 30 min at 37°C (900 rpm shaking, covered from light). After washing with TSM + 0.1% BSA, hMGL binding was detected using an anti‐hisTag FITC‐conjugated antibody (1:20 in TSM + 0.1% BSA, Invitrogen; clone AD1.1.10), incubated for 20 minutes at 4°C, covered from light. FITC-positive and -negative bacteria were sorted and analyzed using a Sony SH800 flow cytometric cell sorter.

To determine binding of CLR constructs to bacterial monocultures, 106 CFU (determined by OD600) or bacterial cells (quantified by flow cytometry) were stained with langerin-FITC or his-hMGL as described above. MGL binding was blocked by adding N-acetyl-galactosamine (GalNAc; 100 mM; Sigma-Aldrich A2795) and langerin binding was blocked through the addition of mannan (20 µg/mL; Sigma-Aldrich M7504). To test for calcium dependent binding, the calcium chelator EGTA (Sigma Aldrich, 10 mM) was added. After washing with TSM + 0.1% BSA, bacteria were fixed with phosphate buffered saline (PBS) + 1% formaldehyde (Sigma-Aldrich) and measured by flow cytometry (BD FACS Canto).

Fecal bacteria isolation and staining

Fecal microbiota was isolated as previously described [14] with some modifications. Approximately 100 mg frozen fecal material was resuspended in 1 mL of ice-cold PBS for 15 minutes on ice. Next, the suspension was transferred to a Fast Prep Lysing Matrix D tube containing 1.4 mm zirconium-silicate beads (MP Biomedicals) and homogenized by beat-beating for 10 seconds at 6,000 rpm (MagNa Lyser; Roche). To separate the fecal bacteria from the debris, the homogenized suspension was centrifuged (50 x g, 15 minutes, 4°C) and 100 µL supernatant was transferred to a clean 1.5 mL Eppendorf tube and washed with 1 mL PBS + 1% BSA (8,000 x g, 5 min, 4°C). The fecal pellet was resuspended in 1 mL PBS + 1% BSA and filtered using a 70 µm mini cell strainer (PluriSelect), after which 20 µL was set aside as pre-sort sample.

To determine CLR-specific binding of fecal bacteria, the filtered microbiota suspension was centrifuged and stained with 25 µg/mL recombinant human langerin-FITC or his-tagged human MGL in TSM + 1% BSA, and incubated 30 minutes at 37°C with agitation (600 rpm). MGL-stained bacteria were stained with anti-his-FITC after washing (1:20 in TSM + 1% BSA; Invitrogen, clone AD1.1.10) for 20 minutes at 4°C, covered from light. For IgA sorting, fecal bacteria were stained with PE anti-human IgA (Miltenyi Biotec, clone IS11-8E10; 1:10 in PBS + 1% BSA) and incubated 30 minutes on ice. Samples were washed with and resuspended in TSM + 1% BSA and analyzed by flow cytometry measuring 20,000 events (FACSymphony A1, BD Biosciences), or sorted based on fluorescent staining using fluorescence-activated cell sorting (Sony SH800). For cell sorting, the percentage of positive events was measured and 200,000 positive events per staining were collected in PBS + 1% BSA, pelleted by centrifugation (8,000 x g, 5 min, 4°C), resuspended in 50 µL PBS and stored at −20°C until DNA extraction.

DNA extraction, 16S rRNA gene sequencing

Fecal DNA extraction, 16S rRNA gene sequencing analysis, and bioinformatics analysis were performed as described previously [51]. Briefly, total genomic DNA was isolated from the pre-sorted and sorted microbiota samples at the Microbiota Centre of Amsterdam (MiCA, Amsterdam, the Netherlands). Isolation was performed using a repeated bead beating protocol and the Maxwell RSC Whole Blood DNA kit [52]. DNA concentration was measured in a 96-wells plate using the Qubit dsDNA BR Assay. Amplification of the V3-V4 regions of the 16S rRNA gene sequences was performed with the 341F-805R primers in a single step PCR protocol. Sample collection kits containing only solubilizing buffer with no stool samples were used as negative control and were followed for the same extraction steps. Samples were purified using Ampure XP beads, measured and sequenced equimolarly using Illumina MiSeq (v3 chemistry with 2  ×  250 cycles).

Amplicon sequences were parsed using a vsearch (v2.15.2) based pipeline [53]. Paired end reads were merged, with max differences set to 100 and allowing for staggered overlap. Zero-radius Operational Taxonomic Units (zOTUs) were inferred from reads with lower than 1.5 expected error rate using the cluster_unoise with centroids algorithm with a minsize of 4, after which chimeras were removed using the uchime3 denovo method. For each sample zOTU abundances were determined by mapping the merged reads against zOTU sequences using usearch_global with a 0.97 distance cut off. Taxonomy was assigned using R (4.2.0) and the dada2 [54] assign taxonomy function using the silva (v132) [55] reference database. A phylogenetic tree was generated use mafft (v7.310) [35] and Fasttree (2.1.11) [56].

The abundance and zOTU tables were used for downstream analysis using R’s phyloseq package [57]. Probability scores were calculated using Microsoft Excel using relative abundances and sorted fraction size, similarly as described previously [26] and zOTUs that were present in the sorted sample of all three individual donors were included. For visualization of 16S rRNA gene sequencing analysis, R-studio (version 4.4.1) or Graphpad Prism (version 10.2.0) was used.

Statistical analysis

Visualization and statistical analysis were performed using Graphpad Prism (version 10.2.0). Differences in CLR binding at specific concentrations and potential blocking were calculated with a one-way analysis of variance (ANOVA) for each individual species, followed by Bonferroni’s test for multiple comparison. For CLR binding concentration curves, a two-way ANOVA followed by Bonferonni’s multiple-comparison test was used. A p-value of <0.05 was considered significant.

Supporting information

S1 Fig. Soluble MGL and langerin discriminate S. aureus in a synthetic microbial community through specific glycan moieties.

Dot plots of a microbial community consisting of equal proportions of E. coli, A. faecalis, S. thermophilus, L. monocytogenes and various relative abundances (20, 10, 1%) of CTY-labeled S. aureus (visualized in the PE channel). Microbial communities were stained with A recombinant human MGL detected with anti-his-FITC, labeling only spiked-in S. aureus PS187, or B langerin-FITC, labeling only S. aureus N315. The double-positive S. aureus fraction was quantified using flow cytometry.

https://doi.org/10.1371/journal.pone.0356059.s001

(TIF)

S2 Fig. CLRs bind primarily to bacterial particles and the calcium dependence of CLR binding varies between donors.

A Isolated fecal microbiota was stained with the DNA dye SYTO60 to discriminate bacteria from non-animate particles. SYTO60-positive percentages were determined before and after CLR-sorting. Results represent the mean of four individual healthy donor samples. B Effect of calcium chelator EGTA on MGL- and C langerin binding to isolated fecal microbiota. The FITC-positive populations are shown for three individual donors.

https://doi.org/10.1371/journal.pone.0356059.s002

(TIF)

S3 Fig. Changes in bacterial composition after CLR- and IgA-based sorting of fecal microbiota.

A CLR- or IgA-positive bacteria were sorted from fecal samples from three healthy human donors using fluorescence-based cell sorting and analyzed with 16S rRNA gene sequencing. The diversity of species was calculated using Shannon’s Diversity Index. B Relative abundances at the species level of the zOTUs that had a relative abundance of >1% in at least one sorted or unsorted sample across three donors.

https://doi.org/10.1371/journal.pone.0356059.s003

(TIF)

S4 Fig. CLR- and IgA- binding of microbiota species is not affected by relative abundance in the total population.

CLR- or IgA-binding bacteria were sorted from healthy human fecal donor samples using fluorescence-based cell sorting and analyzed with 16S rRNA gene sequencing. Probability scores were calculated by comparing the relative abundances of identified zOTUs in sorted and pre-sorted (total) populations. Average probability scores for each zOTU in the A MGL-sorted, B langerin-sorted and C IgA-sorted fractions were plotted against their respective relative abundance in the total population. Spearman’s rank correlation was used for statistical comparison.

https://doi.org/10.1371/journal.pone.0356059.s004

(TIF)

S5 Fig. Identity of IgA-coated microbiota species based on probability scores.

Positive probability scores were calculated for IgA binding based on relative abundances in 16S rRNA gene sequencing data. The graph shows the bacterial species ranking in the top 10 of the highest (grey background) or lowest average probability scores (white background) for IgA binding. Individual scores for each donor are shown. To avoid potential contaminants introduced during sample collection and downstream work up, we only included zOTUs that were detected in all three donors and had > 0.1% relative abundance in at least two donors in the total (pre-sorted) population. Open circles are used for donors where the zOTUs had < 0.1% relative abundance in the total population.

https://doi.org/10.1371/journal.pone.0356059.s005

(TIF)

S6 Fig. Correlation between probability scores for CLR-positive and IgA-coated microbiota species.

CLR- or IgA-positive bacteria were sorted from fecal samples from three healthy human donors using fluorescence-based cell sorting and analyzed with 16S rRNA gene sequencing. Probability scores were calculated by comparing the relative abundances of identified zOTUs in sorted and pre-sorted (total) populations. Average probability scores for each zOTU in the A MGL-sorted and B langerin-sorted fractions were plotted against their respective IgA probability scores. Only zOTUs that were present in the total population and had a minimal relative abundance of >0.1% in the total population of at least two individual donors were included (n = 251). Spearman’s rank correlation was used for statistical comparison.

https://doi.org/10.1371/journal.pone.0356059.s006

(TIF)

S7 Fig. Validation of bacterial species identified by CLR-seq.

Binding of A recombinant human MGL detected by an anti-his-FITC antibody and B recombinant human langerin-FITC to bacterial species identified by CLR-seq. CLRs were used at a concentration range (0–50 µg/mL). Binding was blocked using N-acetyl-galactosamine (GalNAc) or mannan for MGL and langerin, respectively, and with the calcium chelator EGTA. The indicated statistical differences refer to both blocking conditions compared to the nonblocked control. Data are shown as the mean of the geometric mean fluorescence intensity (FI) ± standard error of mean from three independent experiments. *, p < 0.05; **, p < 0.01; ****,p < 0.0001.

https://doi.org/10.1371/journal.pone.0356059.s007

(TIF)

S1 Table. Relative abundances at the genus level for genera that were among the 10 most abundant genera in at least one sequenced sample.

Data is shown as the percent of total reads.

https://doi.org/10.1371/journal.pone.0356059.s008

(XLSX)

S2 Table. Relative abundances at the genus level for species that were among the 10 most abundant species in at least one sequenced sample.

Data is shown as the percent of total reads.

https://doi.org/10.1371/journal.pone.0356059.s009

(XLSX)

S1 File. Bacterial strains used in this study.

https://doi.org/10.1371/journal.pone.0356059.s010

(PDF)

Acknowledgments

The authors would like to thank Romy Ros and Carla J. C. de Haas for their technical assistance; Dr. Torsten Scheithauer for sharing his expertise with the microbiota sorting process; Jorn Hartman for his help with the preparation of the sequencing library and Professor Christoph Rademacher at the University of Vienna for supplying the recombinant langerin construct.

References

  1. 1. Valdes AM, Walter J, Segal E, Spector TD. Role of the gut microbiota in nutrition and health. BMJ. 2018;361:k2179. pmid:29899036
  2. 2. Morowitz MJ, Carlisle EM, Alverdy JC. Contributions of intestinal bacteria to nutrition and metabolism in the critically ill. Surg Clin North Am. 2011;91(4):771–85, viii. pmid:21787967
  3. 3. Khan I, Bai Y, Zha L, Ullah N, Ullah H, Shah SRH, et al. Mechanism of the Gut Microbiota Colonization Resistance and Enteric Pathogen Infection. Front Cell Infect Microbiol. 2021;11:716299. pmid:35004340
  4. 4. Zeng MY, Cisalpino D, Varadarajan S, Hellman J, Warren HS, Cascalho M. Gut Microbiota-Induced Immunoglobulin G Controls Systemic Infection by Symbiotic Bacteria and Pathogens. Immunity. 2016;44(3):647–58. pmid:26944199
  5. 5. Doron I, Leonardi I, Li XV, Fiers WD, Semon A, Bialt-DeCelie M, et al. Human gut mycobiota tune immunity via CARD9-dependent induction of anti-fungal IgG antibodies. Cell. 2021;184(4):1017–1031.e14. pmid:33548172
  6. 6. Szymanski CM. Bacterial glycosylation, it’s complicated. Front Mol Biosci. 2022;9:1015771. pmid:36250013
  7. 7. Dube DH, Champasa K, Wang B. Chemical tools to discover and target bacterial glycoproteins. Chem Commun (Camb). 2011;47(1):87–101. pmid:20730171
  8. 8. Prado Acosta M, Lepenies B. Bacterial glycans and their interactions with lectins in the innate immune system. Biochem Soc Trans. 2019;47(6):1569–79. pmid:31724699
  9. 9. Lee S, Inzerillo S, Lee GY, Bosire EM, Mahato SK, Song J. Glycan-mediated molecular interactions in bacterial pathogenesis. Trends Microbiol. 2022;30(3):254–67. pmid:34274195
  10. 10. Rappuoli R. Glycoconjugate vaccines: Principles and mechanisms. Sci Transl Med. 2018;10(456):eaat4615. pmid:30158151
  11. 11. Lei C, Wang T, Wang J, Tan Y, Deng Z. Commensal bacterial glycosylation at the interface of host-bacteria interactions. Gut Microbes. 2025;17(1):2545421. pmid:40810484
  12. 12. Geissner A, Reinhardt A, Rademacher C, Johannssen T, Monteiro J, Lepenies B, et al. Microbe-focused glycan array screening platform. Proc Natl Acad Sci U S A. 2019;116(6):1958–67. pmid:30670663
  13. 13. Stowell SR, Arthur CM, McBride R, Berger O, Razi N, Heimburg-Molinaro J, et al. Microbial glycan microarrays define key features of host-microbial interactions. Nat Chem Biol. 2014;10(6):470–6. pmid:24814672
  14. 14. Palm NW, de Zoete MR, Cullen TW, Barry NA, Stefanowski J, Hao L, et al. Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease. Cell. 2014;158(5):1000–10. pmid:25171403
  15. 15. Shapiro JM, de Zoete MR, Palm NW, Laenen Y, Bright R, Mallette M, et al. Immunoglobulin A Targets a Unique Subset of the Microbiota in Inflammatory Bowel Disease. Cell Host Microbe. 2021;29(1):83–93.e3. pmid:33385335
  16. 16. Oinam L, Minoshima F, Tateno H. Glycan profiling of the gut microbiota by Glycan-seq. ISME Commun. 2022;2(1):1. pmid:37938656
  17. 17. McPherson RL, Isabella CR, Walker RL, Sergio D, Bae S, Gaca T, et al. Lectin-Seq: A method to profile lectin-microbe interactions in native communities. Sci Adv. 2023;9(30):eadd8766. pmid:37506208
  18. 18. Mnich ME, van Dalen R, van Sorge NM. C-Type Lectin Receptors in Host Defense Against Bacterial Pathogens. Front Cell Infect Microbiol. 2020;10:309. pmid:32733813
  19. 19. Rescigno M, Urbano M, Valzasina B, Francolini M, Rotta G, Bonasio R, et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol. 2001;2(4):361–7. pmid:11276208
  20. 20. Allen F, Tong AA, Huang AY. Unique Transcompartmental Bridge: Antigen-Presenting Cells Sampling across Endothelial and Mucosal Barriers. Front Immunol. 2016;7:231. pmid:27375624
  21. 21. Tanaka J, Gleinich AS, Zhang Q, Whitfield R, Kempe K, Haddleton DM, et al. Specific and Differential Binding of N-Acetylgalactosamine Glycopolymers to the Human Macrophage Galactose Lectin and Asialoglycoprotein Receptor. Biomacromolecules. 2017;18(5):1624–33. pmid:28418238
  22. 22. Hanske J, Schulze J, Aretz J, McBride R, Loll B, Schmidt H, et al. Bacterial Polysaccharide Specificity of the Pattern Recognition Receptor Langerin Is Highly Species-dependent. J Biol Chem. 2017;292(3):862–71. pmid:27903635
  23. 23. Mnich ME, van Dalen R, Gerlach D, Hendriks A, Xia G, Peschel A, et al. The C-type lectin receptor MGL senses N-acetylgalactosamine on the unique Staphylococcus aureus ST395 wall teichoic acid. Cell Microbiol. 2019;21(10):e13072. pmid:31219660
  24. 24. van Dalen R, De La Cruz Diaz JS, Rumpret M, Fuchsberger FF, van Teijlingen NH, Hanske J, et al. Langerhans Cells Sense Staphylococcus aureus Wall Teichoic Acid through Langerin To Induce Inflammatory Responses. mBio. 2019;10(3):e00330–19. pmid:31088921
  25. 25. Zelensky AN, Gready JE. The C-type lectin-like domain superfamily. FEBS J. 2005;272(24):6179–217. pmid:16336259
  26. 26. Jackson MA, Pearson C, Ilott NE, Huus KE, Hegazy AN, Webber J, et al. Accurate identification and quantification of commensal microbiota bound by host immunoglobulins. Microbiome. 2021;9(1):33. pmid:33516266
  27. 27. Campanero-Rhodes MA, Palma AS, Menéndez M, Solís D. Microarray Strategies for Exploring Bacterial Surface Glycans and Their Interactions With Glycan-Binding Proteins. Front Microbiol. 2020;10:2909. pmid:32010066
  28. 28. Afzaal M, Saeed F, Shah YA, Hussain M, Rabail R, Socol CT, et al. Human gut microbiota in health and disease: Unveiling the relationship. Front Microbiol. 2022;13:999001. pmid:36225386
  29. 29. Bambauer A, Rainey FA, Stackebrandt E, Winter J. Characterization of Aquamicrobium defluvii gen. nov. sp. nov., a thiophene-2-carboxylate-metabolizing bacterium from activated sludge. Arch Microbiol. 1998;169(4):293–302. pmid:9531630
  30. 30. Menberu MA, Cooksley C, Ramezanpour M, Bouras G, Wormald P-J, Psaltis AJ, et al. In vitro and in vivo evaluation of probiotic properties of Corynebacterium accolens isolated from the human nasal cavity. Microbiol Res. 2022;255:126927. pmid:34875424
  31. 31. Yassin AF, Steiner U, Ludwig W. Corynebacterium appendicis sp. nov. Int J Syst Evol Microbiol. 2002;52(Pt 4):1165–9. pmid:12148623
  32. 32. Saba K, Denda-Nagai K, Irimura T. A C-type lectin MGL1/CD301a plays an anti-inflammatory role in murine experimental colitis. Am J Pathol. 2009;174(1):144–52. pmid:19095961
  33. 33. van Vliet SJ, Gringhuis SI, Geijtenbeek TBH, van Kooyk Y. Regulation of effector T cells by antigen-presenting cells via interaction of the C-type lectin MGL with CD45. Nat Immunol. 2006;7(11):1200–8. pmid:16998493
  34. 34. Jameson B, Baribaud F, Pöhlmann S, Ghavimi D, Mortari F, Doms RW, et al. Expression of DC-SIGN by dendritic cells of intestinal and genital mucosae in humans and rhesus macaques. J Virol. 2002;76(4):1866–75. pmid:11799181
  35. 35. Pyclik M, Srutkova D, Schwarzer M, Górska S. Bifidobacteria cell wall-derived exo-polysaccharides, lipoteichoic acids, peptidoglycans, polar lipids and proteins - their chemical structure and biological attributes. Int J Biol Macromol. 2020;147:333–49. pmid:31899242
  36. 36. Huus KE, Petersen C, Finlay BB. Diversity and dynamism of IgA-microbiota interactions. Nat Rev Immunol. 2021;21(8):514–25. pmid:33568782
  37. 37. Sterlin D, Fadlallah J, Adams O, Fieschi C, Parizot C, Dorgham K, et al. Human IgA binds a diverse array of commensal bacteria. J Exp Med. 2020;217(3):e20181635. pmid:31891367
  38. 38. Huang J, Guerrero A, Parker E, Strum JS, Smilowitz JT, German JB, et al. Site-specific glycosylation of secretory immunoglobulin A from human colostrum. J Proteome Res. 2015;14(3):1335–49. pmid:25629924
  39. 39. Geijtenbeek TBH, Gringhuis SI. Signalling through C-type lectin receptors: shaping immune responses. Nat Rev Immunol. 2009;9(7):465–79. pmid:19521399
  40. 40. Reis e Sousa C, Yamasaki S, Brown GD. Myeloid C-type lectin receptors in innate immune recognition. Immunity. 2024;57(4):700–17. pmid:38599166
  41. 41. Ouchi T, Kubo A, Yokouchi M, Adachi T, Kobayashi T, Kitashima DY, et al. Langerhans cell antigen capture through tight junctions confers preemptive immunity in experimental staphylococcal scalded skin syndrome. J Exp Med. 2011;208(13):2607–13. pmid:22143886
  42. 42. Niess JH, Brand S, Gu X, Landsman L, Jung S, McCormick BA, et al. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science. 2005;307(5707):254–8. pmid:15653504
  43. 43. Baranov M, Ter Beest M, Reinieren-Beeren I, Cambi A, Figdor CG, van den Bogaart G. Podosomes of dendritic cells facilitate antigen sampling. J Cell Sci. 2014;127(Pt 5):1052–64. pmid:24424029
  44. 44. Kubo A, Nagao K, Yokouchi M, Sasaki H, Amagai M. External antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriers. J Exp Med. 2009;206(13):2937–46. pmid:19995951
  45. 45. Scheithauer TPM, Wortelboer K, Winkelmeijer M, Verdoes X, Aydin Ö, Acherman YIZ, et al. Bacteriophages from treatment-naïve type 2 diabetes individuals drive an inflammatory response in human co-cultures of dendritic cells and T cells. Gut Microbes. 2024;16(1):2380747. pmid:39068518
  46. 46. van Muijlwijk GH, van Mierlo G, Jansen PWTC, Vermeulen M, Bleumink-Pluym NMC, Palm NW, et al. Identification of Allobaculum mucolyticum as a novel human intestinal mucin degrader. Gut Microbes. 2021;13(1):1966278. pmid:34455931
  47. 47. Bui TPN, Mannerås-Holm L, Puschmann R, Wu H, Troise AD, Nijsse B, et al. Conversion of dietary inositol into propionate and acetate by commensal Anaerostipes associates with host health. Nat Commun. 2021;12(1):4798. pmid:34376656
  48. 48. van Sorge NM, Bonsor DA, Deng L, Lindahl E, Schmitt V, Lyndin M, et al. Bacterial protein domains with a novel Ig-like fold target human CEACAM receptors. EMBO J. 2021;40(7):e106103. pmid:33522633
  49. 49. Zhao Y, van Woudenbergh E, Zhu J, Heck AJR, van Kessel KPM, de Haas CJC, et al. The Orphan Immune Receptor LILRB3 Modulates Fc Receptor-Mediated Functions of Neutrophils. J Immunol. 2020;204(4):954–66. pmid:31915259
  50. 50. Hendriks A, van Dalen R, Ali S, Gerlach D, van der Marel GA, Fuchsberger FF, et al. Impact of Glycan Linkage to Staphylococcus aureus Wall Teichoic Acid on Langerin Recognition and Langerhans Cell Activation. ACS Infect Dis. 2021;7(3):624–35. pmid:33591717
  51. 51. Gul F, Herrema H, Davids M, Keating C, Nasir A, Ijaz UZ, et al. Gut microbial ecology and exposome of a healthy Pakistani cohort. Gut Pathog. 2024;16(1):5. pmid:38254227
  52. 52. Costea PI, Zeller G, Sunagawa S, Pelletier E, Alberti A, Levenez F, et al. Towards standards for human fecal sample processing in metagenomic studies. Nat Biotechnol. 2017;35(11):1069–76. pmid:28967887
  53. 53. Rognes T, Flouri T, Nichols B, Quince C, Mahé F. VSEARCH: a versatile open source tool for metagenomics. PeerJ. 2016;4:e2584. pmid:27781170
  54. 54. Callahan BJ, Wong J, Heiner C, Oh S, Theriot CM, Gulati AS, et al. High-throughput amplicon sequencing of the full-length 16S rRNA gene with single-nucleotide resolution. Nucleic Acids Res. 2019;47(18):e103. pmid:31269198
  55. 55. Yilmaz P, Parfrey LW, Yarza P, Gerken J, Pruesse E, Quast C, et al. The SILVA and “All-species Living Tree Project (LTP)” taxonomic frameworks. Nucleic Acids Res. 2014;42(Database issue):D643–8. pmid:24293649
  56. 56. Price MN, Dehal PS, Arkin AP. FastTree 2--approximately maximum-likelihood trees for large alignments. PLoS One. 2010;5(3):e9490. pmid:20224823
  57. 57. McMurdie PJ, Holmes S. Shiny-phyloseq: Web application for interactive microbiome analysis with provenance tracking. Bioinformatics. 2015;31(2):282–3. pmid:25262154